Thus, from an initial OR = 1.52 conferred by DRB1*03:01, we moved to OR = 1.94 caused by the specific AH 18.2 to MS overall and to OR = 2.98 when we consider specifically M+ patients. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.